Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
366 participants
OBSERVATIONAL
2024-05-25
2025-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to develop and validate a machine learning based model to predict the length of hospital stay for hip fracture patients after PACU. Different machine learning algorithms such as R language Gradient Boosting, Random Forest, Artificial Neural Networks and Logistic Regression will be used in the study and the best performing model will be determined. In addition, the prediction mechanism of the model will be examined with SHAP analysis and its applicability in clinical decision processes will be evaluated. Thus, by predicting the length of hospital stay, clinicians will be enabled to manage patient care processes more effectively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low- vs. Normal-Flow Anesthesia and Delirium After Hip Fracture in the Elderly
NCT06973967
Risk Early Warning Management for Postoperative Hip Fracture Rehabilitation and Delirium Prevention in Elderly Patients
NCT06966947
Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergoing Hip Fracture Surgery
NCT06818409
Effect of Rebound Pain on Postoperative Intensive Care Delirium in Patients Undergoing Hip Surgery With Peripheral Nerve Block
NCT07295184
The Safety of Anesthesia Management for Traumatic Hip Surgery in Elderly
NCT02692989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
> 7 days LOS
This cohort includes patients whose postoperative hospital length of stay exceeded 7 days. The group was formed based on the median LOS determined in the overall study population. No intervention was administered. The group is used for training and evaluating a machine learning model aimed at predicting prolonged hospitalization (\>7 days) based on preoperative and intraoperative clinical features.
No interventions assigned to this group
<= 7 days LOS
This cohort includes patients whose postoperative hospital length of stay was 7 days or less. The grouping was based on the median LOS observed in the total sample to ensure balanced classification for the machine learning model. No intervention was administered. Clinical data were used to train and test an AI algorithm for hospital LOS prediction.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged 65 years or older
* Patients with hip fractures resulting from a low-energy trauma (simple fall from standing height)
Exclusion Criteria
* Cancer patients with multiple organ metastases
* Patients who underwent revision hip fracture surgery
65 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Volkan Alparslan
Asist. Prof. M.D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kocaeli University
İzmit, Kocaeli̇, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GOKAEK-2024/06.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.